News Focus
News Focus
Post# of 257661
Next 10
Followers 843
Posts 123040
Boards Moderated 9
Alias Born 09/05/2002

Re: RockRat post# 115819

Wednesday, 03/16/2011 8:27:23 AM

Wednesday, March 16, 2011 8:27:23 AM

Post# of 257661
AMLN/Takeda halt phase-2 obesity trial for safety reasons:

http://finance.yahoo.com/news/Amylin-and-Takeda-Voluntarily-prnews-3297796689.html?x=0&.v=1

The trial had been testing the combination of Symlin and metreleptin.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today